Literature DB >> 19689730

An integrated view of the regulation of NKG2D ligands.

Noam Stern-Ginossar1, Ofer Mandelboim.   

Abstract

NKG2D is one of the best characterized activating receptors and is expressed on natural killer cells and on various T-cell subsets. This receptor recognizes several different ligands that are induced by cellular stresses. In this review, we described the mechanisms controlling the expression of NKG2D ligands, with the emphasis on post-transcriptional and post-translational regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19689730      PMCID: PMC2747133          DOI: 10.1111/j.1365-2567.2009.03147.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.

Authors:  P Li; D L Morris; B E Willcox; A Steinle; T Spies; R K Strong
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

3.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Authors:  A Diefenbach; A M Jamieson; S D Liu; N Shastri; D H Raulet
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

5.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

Authors:  A Cerwenka; A B Bakker; T McClanahan; J Wagner; J Wu; J H Phillips; L L Lanier
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

6.  Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

Authors:  Noam Stern-Ginossar; Chamutal Gur; Moshe Biton; Elad Horwitz; Moran Elboim; Noa Stanietsky; Michal Mandelboim; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

7.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Authors:  Daphna Nachmani; Noam Stern-Ginossar; Ronit Sarid; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

8.  Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Authors:  Nicole Schwinn; Daria Vokhminova; Antje Sucker; Sonja Textor; Sandra Striegel; Iris Moll; Norman Nausch; Jochen Tuettenberg; Alexander Steinle; Adelheid Cerwenka; Dirk Schadendorf; Annette Paschen
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

9.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.

Authors:  Nadia Guerra; Ying Xim Tan; Nathalie T Joncker; Augustine Choy; Fermin Gallardo; Na Xiong; Susan Knoblaugh; Dragana Cado; Norman M Greenberg; Norman R Greenberg; David H Raulet
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

10.  Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.

Authors:  Timothy J Nice; Laurent Coscoy; David H Raulet
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

View more
  45 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.

Authors:  A Baragaño Raneros; V Martín-Palanco; A F Fernandez; R M Rodriguez; M F Fraga; C Lopez-Larrea; B Suarez-Alvarez
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

3.  NKG2D receptor regulates human effector T-cell cytokine production.

Authors:  Amorette Barber; Charles L Sentman
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

4.  Role natural killer group 2D-ligand interactions in hepatitis B infection.

Authors:  Teresa Pollicino; Lemonica Koumbi
Journal:  World J Hepatol       Date:  2015-04-28

5.  Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1.

Authors:  Leonidas N Carayannopoulos; Jennifer L Barks; Wayne M Yokoyama; Joan K Riley
Journal:  Biol Reprod       Date:  2010-05-19       Impact factor: 4.285

6.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

7.  The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.

Authors:  Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O Gollnick
Journal:  Lasers Surg Med       Date:  2012-01-03       Impact factor: 4.025

8.  NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Authors:  Jessica E Thaxton; Tania Nevers; Eliana O Lippe; Sandra M Blois; Shigeru Saito; Surendra Sharma
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  MICA variant promotes allosensitization after kidney transplantation.

Authors:  Pierre Tonnerre; Nathalie Gérard; Mathias Chatelais; Caroline Poli; Stéphanie Allard; Sylvie Cury; Céline Bressollette; Anne Cesbron-Gautier; Béatrice Charreau
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

10.  NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo.

Authors:  Saravanan Raju; Lena Z Kretzmer; Olivia I Koues; Jacqueline E Payton; Eugene M Oltz; Amanda Cashen; Bojan Polic; Robert D Schreiber; Andrey S Shaw; Mary A Markiewicz
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.